Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

ValiRx Shares Show High-Beta Profile on Tiny Valuation and Binary Scientific News

ValiRx, a drug developer focused on early-stage cancer therapeutics and women's health, has been showing high-beta characteristics. Market data on 24 September 2026 showed a one-yearBetaof 1.42.

Divya Sood | 24 September 2026

Why IXICO (IXI) Is Suddenly Drawing Healthcare Investors’ Attention Against the FTSE AIM All-Share

IXICO (LSE:IXI) analyses brain scans for pharmaceutical and biotech companies runningClinical Trialsin neurological diseases such as Huntington's, Alzheimer's and Parkinson's. Its shares were among the most volatile UK stocks on 23 September 2026.

Ankur Sharma | 24 September 2026

Why Incanthera (INC) Is Turning Heads on the AQSE Growth Market

Incanthera plc (LSE:INC) was among the most volatile UK stocks on 23 September 2026. Since early June the company has acquired a Swiss skincareBrandfor shares, replaced its chief executive and chairman and, on 7 September, announced an exclusive supply agreement with UK LED skincare …

Ankur Sharma | 24 September 2026

Why Cizzle Biotechnology (CIZ) Is Becoming a High-Drama Biotech Name on the London Stock Exchange Main Market

Cizzle Biotechnology (LSE:CIZ) is a UK diagnostics developer whose lead product is a blood test for the CIZ1B biomarker, which the company says is highly associated with early-stage lung cancer. Its shares were among the most volatile on the UK market on 23 September …

Ankur Sharma | 24 September 2026

Why EDX Medical Group (EDX) Is Becoming a Volatile Healthcare Name Against the FTSE AIM All-Share

EDX Medical Group plc (LSE:EDX) appeared among the most volatile UK stocks on 23 September 2026. The company's shares began trading on AIM on 13 May 2026 after moving from the Apex segment of the Aquis Stock Exchange Growth Market. This article uses the …

Ankur Sharma | 24 September 2026

Why Imaging Biometrics (IBAI) Is Suddenly on Traders’ Radar on the London Stock Exchange Main Market

Imaging Biometrics (LSE:IBAI), formerly IQ-AI Limited, featured among the most volatile UK stocks on 23 September 2026. The Jersey-incorporated group develops quantitative MRI software for neuro-oncology through its US subsidiary, Imaging Biometrics LLC, and owns Kirkstall, an organ-on-a-chip business.

Ankur Sharma | 24 September 2026

Why Futura Medical (FUM) Is Back in Focus Against the FTSE AIM All-Share

Futura Medical plc (LSE:FUM) featured among the most volatile UK stocks on 23 September 2026, the same day shareholders were due to vote on its latest fundraising at a general meeting. The company is quoted on AIM; this article uses the FTSE AIM All-Share …

Ankur Sharma | 24 September 2026

Why ImmuPharma (IMM) Is Back on Traders’ Radar Against the FTSE AIM All-Share

ImmuPharma plc (LSE:IMM) was among the most volatile UK stocks on 23 September 2026. The company's shares trade on AIM, the London Stock Exchange's growth market.

Ankur Sharma | 24 September 2026

Why CRISM Therapeutics (CRTX) Is Becoming a Volatile Biotech Name Against the FTSE AIM All-Share

CRISM Therapeutics (LSE:CRTX) was among the most volatile UK stocks on 23 September 2026. The company is a clinical-stage drug-deliveryBusinessdeveloping ChemoSeed, a biodegradable implant that releases chemotherapy directly into tumour tissue. Its lead target is glioblastoma, an aggressive brain cancer.

Ankur Sharma | 24 September 2026

How CVS Group (LSE:CVSG) built one of the UK's largest vet networks

CVS (LSE:CVSG) grew by repeating one approach: buy local practices, keep their local identity, and add group-wide purchasing, diagnostics, online retail and a pet health subscription scheme. Simon Innis, chief executive from 2004, oversaw most of the UK roll-up. Richard Fairman, chief executive since …

Ankur Sharma | 23 September 2026
Support

Hi! How can we help you today?

Loading…